Public Release: 

New open-access journal on Case Reports in Pancreatic Cancer launching fall 2015

Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, June 15, 2015--Case Reports in Pancreatic Cancer, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, will deliver authoritative case reports on all aspects of pancreatic cancer diagnosis, management, treatment, and outcomes. Launching in fall 2015, the Journal will be the premier open source for clinical reports on the disease, and will publish under the Creative Commons Attribution 4.0 (CC BY) license to ensure broad dissemination and participation.

Pancreatic cancer rates have risen steadily for several years, and the disease results in more than 300,000 deaths globally each year. It is the fourth most common cause of cancer deaths in the U.S., and has a five-year survival rate of less than 25%. There are large disparities in pancreatic cancer diagnosis and survival rates, with a disease risk of over 50% greater for African Americans.

"Case Reports in Pancreatic Cancer enables surgeons, oncologists, and the team of professionals that determine and administer care to share their experiences and foster communication and collaboration to optimize patient care," said Mary Ann Liebert, founder, President, and CEO of the company that bears her name. "These case studies are an imperative for translational research that will move forward more options for treatment and cure."


For information on manuscript submission or to sign up for email alerts for Case Reports in Pancreatic Cancer, please contact us at

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cancer Biotherapy and Radiopharmaceuticals, Journal of Adolescent and Young Adult Oncology, and Journal of Interferon & Cytokine Research. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.